| Follow-up | |
 | 
Discharge patients at the appropriate time, and arrange follow-up to look for disease sequelae. |
- Discharge patients when the following criteria are met:
- Absence of fever for at least 24 hours without the use of antipyretics
- A minimum of 3 days after recovery from dengue shock syndrome with stable pulse, blood pressure, and respiratory rate
- No respiratory distress from a pleural effusion and no ascites
- No evidence of internal or external bleeding
- Good urinary output and stable hematocrit
- Platelet count >50 × 109/L, if the count is increasing
- Presence of a convalescent confluent rash
- At follow-up visits, ask about:
- Anorexia
- Joint and muscle pain
- Fatigue and depression
- Bleeding manifestations
- At follow-up visits, examine the patient for:
- Bleeding manifestations
- Hepatomegaly
- Provide general advice and treatment of symptoms as needed for any persistent clinical manifestations, such as fatigue, after recovery from the acute illness.
- See table Elements of Follow-up for Dengue.
| Background
|  | | FAQs |
|
|
Bandula Wijesiriwardena, MD, FRCP, FCCP, FCMSA, FRACP, FACP has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Panduka Karunanayake, MD, MRCP has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Suranjith L. Seneviratne, MD, DPhil, MRCP, FRCPath has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Deborah Korenstein, MD, FACP, Co-Editor, PIER, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Richard B. Lynn, MD, FACP, Co-Editor, PIER, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. |